1. Home
  2. TOWN vs IBRX Comparison

TOWN vs IBRX Comparison

Compare TOWN & IBRX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • TOWN
  • IBRX
  • Stock Information
  • Founded
  • TOWN 1998
  • IBRX 2014
  • Country
  • TOWN United States
  • IBRX United States
  • Employees
  • TOWN N/A
  • IBRX N/A
  • Industry
  • TOWN Major Banks
  • IBRX Biotechnology: Biological Products (No Diagnostic Substances)
  • Sector
  • TOWN Finance
  • IBRX Health Care
  • Exchange
  • TOWN Nasdaq
  • IBRX Nasdaq
  • Market Cap
  • TOWN 2.3B
  • IBRX 2.4B
  • IPO Year
  • TOWN 1999
  • IBRX N/A
  • Fundamental
  • Price
  • TOWN $34.20
  • IBRX $3.15
  • Analyst Decision
  • TOWN Buy
  • IBRX Strong Buy
  • Analyst Count
  • TOWN 2
  • IBRX 5
  • Target Price
  • TOWN $40.50
  • IBRX $11.40
  • AVG Volume (30 Days)
  • TOWN 224.7K
  • IBRX 9.7M
  • Earning Date
  • TOWN 07-23-2025
  • IBRX 05-12-2025
  • Dividend Yield
  • TOWN 3.16%
  • IBRX N/A
  • EPS Growth
  • TOWN 18.01
  • IBRX N/A
  • EPS
  • TOWN 2.36
  • IBRX N/A
  • Revenue
  • TOWN $715,943,000.00
  • IBRX $31,222,000.00
  • Revenue This Year
  • TOWN $19.91
  • IBRX $564.61
  • Revenue Next Year
  • TOWN $16.25
  • IBRX $161.88
  • P/E Ratio
  • TOWN $14.49
  • IBRX N/A
  • Revenue Growth
  • TOWN 6.71
  • IBRX 10238.41
  • 52 Week Low
  • TOWN $25.70
  • IBRX $1.83
  • 52 Week High
  • TOWN $38.28
  • IBRX $7.63
  • Technical
  • Relative Strength Index (RSI)
  • TOWN 51.21
  • IBRX 66.26
  • Support Level
  • TOWN $33.35
  • IBRX $2.62
  • Resistance Level
  • TOWN $34.59
  • IBRX $2.88
  • Average True Range (ATR)
  • TOWN 0.49
  • IBRX 0.23
  • MACD
  • TOWN -0.14
  • IBRX 0.06
  • Stochastic Oscillator
  • TOWN 42.71
  • IBRX 80.90

About TOWN TowneBank

Towne Bank is a financial services company that places special emphasis on serving the financial needs of individuals, commercial enterprises, and professionals, offering retail and commercial banking services to numerous markets in Virginia and North Carolina. The company has three reportable segments: Banking Segment provides loan and deposit services to retail and commercial customers and provides commercial mortgage brokerage services and investment and asset management services, and the Realty Segment provides residential real estate services and mortgage loans. It also provides resort property management and residential and commercial title insurance, and Insurance Segment provides provide a wide array of insurance products, including property, casualty, life, and health insurance.

About IBRX ImmunityBio Inc.

ImmunityBio Inc is an integrated clinical-stage biotechnology company discovering, developing, and commercializing next-generation immuno- and cellular therapies that bolster the natural immune system to drive and sustain an immune response. Its platforms for the development of biologic product candidates include (i) antibody-cytokine fusion proteins, (ii) DNA, RNA, and recombinant protein vaccines, and (iii) cell therapies. Its focus includes bladder, lung, and colorectal cancers and GBM and its product candidate Anktiva is an IL-15 superagonist antibody-cytokine fusion protein. It has two geographical segments: the United States and Europe. Key revenue is generated from the United States.

Share on Social Networks: